Hovedparten af disse patienter var i samtidig behandling med acetylsalicylsyre og clopidogrel – og 6 ud af de 10 patienter fik derudover en GPIIb/ IIIa- inhibitor.
The majority of these patients received concomitant acetylsalicylic acid and clopidogrel, and 6 out of the 10 patients also received a GPIIb/ IIIa inhibitor.